V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003648 | 310006661 | 1.83 | 106.4 | Neo-adjuvant (N) | 2017-04-17 | 2017-04-24 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 310018366 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003649 | 310010352 | 1.73 | 60.8 | Palliative (P) | 2018-03-15 | 2018-03-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018370 | CAPECITABINE + CISPLATIN |
| 310003650 | 310001526 | 1.92 | null | Disease modification (D) | 2013-09-29 | 2013-09-29 | Hydroxycarbamide | N | N | 310018371 | EOX |
| 310003651 | 310006662 | null | null | null | 2014-10-23 | 2014-10-24 | CHOEP - 21 days | N | N | 310018372 | CHOEP |
| 310003652 | 310001527 | 1.7 | 85 | Palliative (P) | 2016-03-17 | 2016-03-30 | GEMCITABINE | Y | N | 310018374 | GEMCITABINE |
| 310003653 | 310006663 | null | null | Palliative (P) | 2015-11-24 | 2016-02-01 | Dacarbazine | 02 | null | 310018376 | OXALIPLATIN + MDG |
| 310003654 | 310006663 | 1.6 | 77 | Not known (9) | 2017-03-22 | 2017-03-23 | Mitomycin Intravesical | null | null | 310018376 | RITUXIMAB |
| 310003655 | 310006663 | 1.72 | 69.2 | Curative (C) | 2017-03-19 | 2017-03-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018376 | BEXAROTENE |
| 310003656 | 310001528 | null | 74 | Palliative (P) | 2013-05-03 | 2013-05-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 310018386 | OXALIPLATIN + MDG |
| 310003657 | 310001529 | 0 | 68 | Palliative (P) | 2016-02-14 | 2016-02-24 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310018387 | GEMCITABINE |
| 310003658 | 310001530 | 1.53 | 70.3 | Neo-adjuvant (N) | 2017-02-15 | 2017-02-27 | CAPECITABINE + OXALIPLATIN | N | N | 310018389 | CAPECITABINE |
| 310003659 | 310001531 | 1.74 | 80 | Curative (C) | 2016-08-23 | 2016-08-24 | Rituximab | N | N | 310018395 | ICON TRIAL |
| 310003660 | 310001531 | null | null | Curative (C) | 2016-12-29 | 2017-01-31 | Capecitabine + Oxaliplatin 21day | 2 | N | 310018395 | EOX |
| 310003661 | 310001531 | 1.58 | 83 | Palliative (P) | 2015-10-26 | 2015-11-09 | GEMCITABINE | N | N | 310018395 | GEMCITABINE |
| 310003662 | 310001531 | 1.68 | null | Palliative (P) | 2016-03-02 | 2016-03-03 | Oxaliplatin + Modified de Gramont | 02 | N | 310018395 | CAPECITABINE + OXALIPLATIN |
| 310003663 | 310001531 | 1.73 | 58 | Palliative (P) | 2017-07-03 | 2017-07-21 | Cisplatin +Fluorouracil (3 wk) | N | N | 310018395 | HYDROXYCARBAMIDE |
| 310003664 | 310001531 | 1.75 | 96 | Curative (C) | 2014-06-14 | 2014-06-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310018395 | EOX |
| 310003665 | 310001532 | 1.59 | 54.9 | Palliative (P) | null | 2014-08-28 | CHOEP - 21 days | 02 | N | 310018415 | CHOEP |
| 310003666 | 310006665 | 1.71 | 94.2 | Radical (R) | 2017-10-23 | 2017-10-23 | Liposomal Doxorubicin (Caelyx) | null | null | 310018417 | CAPECITABINE + CISPLATIN |
| 310003667 | 310006665 | 1.72 | 52.8 | null | 2014-09-09 | 2014-09-10 | Imatinib 400mg | 02 | N | 310018417 | LIPOSOMAL DOXORUBICIN |
| 310003668 | 310001533 | 1.6 | 92.3 | Disease modification (D) | 2017-06-22 | 2017-06-28 | Hydroxycarbamide | N | N | 310018419 | DACARBAZINE |
| 310003669 | 310006666 | 1.55 | 72.15 | Curative (C) | 2014-11-04 | 2014-12-06 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 310018421 | NOT MATCHED |
| 310003670 | 310001534 | 1.66 | 66 | Curative (C) | 2015-04-12 | 2015-04-12 | Capecitabine + Oxaliplatin 21day | 2 | null | 310018423 | GEMCITABINE + PACLITAXEL |
| 310003671 | 310001534 | 1.67 | 66.1 | Palliative (P) | 2015-02-07 | 2015-02-14 | IPILIMUMAB + NIVOLUMAB | N | N | 310018423 | IPILIMUMAB + NIVOLUMAB |
| 310003672 | 310001534 | 1.63 | 81.5 | Disease modification (D) | 2015-10-27 | 2015-11-05 | Rituximab | 02 | N | 310018423 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003673 | 310001535 | 1.73 | 57.7 | Disease modification (D) | 2016-03-10 | 2017-03-09 | Capecitabine + Oxaliplatin 21day | Y | N | 310018428 | CAPECITABINE |
| 310003674 | 310001536 | 1.74 | null | Palliative (P) | 2015-02-05 | 2015-02-05 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018432 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003675 | 310001537 | 1.31 | 109.2 | Palliative (P) | null | 2017-10-04 | CISPLATIN + FLUOROURACIL | N | N | 310018433 | CAPECITABINE + CISPLATIN |
| 310003676 | 310001537 | 1.78 | 69.2 | Palliative (P) | 2015-01-27 | 2015-02-03 | IPILIMUMAB + NIVOLUMAB | N | N | 310018433 | IPILIMUMAB + NIVOLUMAB |
| 310003677 | 310001537 | 0 | 0 | Palliative (P) | 2016-10-08 | 2016-11-03 | Oxaliplatin + Modified de Gramont | N | N | 310018433 | CAPECITABINE + CISPLATIN |
| 310003678 | 310001537 | 1.89 | 101 | Palliative (P) | 2014-07-24 | 2015-03-13 | null | N | null | 310018433 | NOT MATCHED |
| 310003679 | 310001537 | 1.6 | 66.5 | Palliative (P) | 2016-12-01 | 2016-12-05 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310018433 | IPILIMUMAB + NIVOLUMAB |
| 310003680 | 310001538 | null | 68.7 | Palliative (P) | 2017-07-20 | 2017-07-27 | Bexarotene | 1 | null | 310018446 | VEMURAFENIB |
| 310003681 | 310001539 | 1.73 | 70 | Curative (C) | 2016-01-31 | 2016-06-30 | IPILIMUMAB + NIVOLUMAB | 01 | N | 310018451 | MITOMYCIN INTRAVESICULAR |
| 310003682 | 310001540 | 2 | 87.6 | Disease modification (D) | 2010-12-12 | 2014-10-19 | Gemcitabine day 1&8 | 02 | null | 310018452 | PACLITAXEL |
| 310003683 | 310006669 | 1.84 | null | Curative (C) | 2013-09-20 | 2013-09-20 | CHOEP - 21 days | N | N | 310018453 | CHOEP |
| 310003685 | 310001542 | 1.79 | null | Disease modification (D) | 2016-11-01 | 2016-11-05 | Rituximab | N | N | 310018455 | VEMURAFENIB |
| 310003686 | 310001543 | 1.63 | 80.3 | Adjuvant (A) | 2013-10-28 | 2013-12-08 | Gemcitabine weekly | N | N | 310018458 | GEMCITABINE |
| 310003687 | 310001544 | 1.86 | 0 | Palliative (P) | 2013-04-22 | 2013-05-06 | ECX | 02 | null | 310018459 | ECX |
| 310003688 | 310001545 | 1.49 | 74.7 | Palliative (P) | 2016-12-15 | 2016-12-26 | IMATINIB | 2 | N | 310018460 | OXALIPLATIN + MDG |
| 310003689 | 310001546 | 1.63 | 45.2 | Palliative (P) | 2013-05-05 | 2013-05-11 | Capecitabine + Oxaliplatin 21day | null | null | 310018463 | EOX |
| 310003690 | 310006670 | 0 | 84.4 | null | 2014-04-04 | 2014-04-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310018464 | BCG |
| 310003691 | 310009092 | null | 107.5 | Palliative (P) | 2013-08-05 | 2013-08-16 | Imatinib 400mg | N | Y | 310018465 | EOX |
| 310003692 | 310009092 | 1.8 | 89.7 | Neo-adjuvant (N) | 2013-07-23 | 2013-07-26 | Oxaliplatin + Modified de Gramont | null | N | 310018465 | VEMURAFENIB |
| 310003693 | 310001547 | 1.66 | 67.8 | Disease modification (D) | 2013-08-12 | 2013-08-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018467 | EOX |
| 310003694 | 310001547 | 1.7 | 0 | Disease modification (D) | 2015-09-19 | 2015-09-19 | Rituximab | 02 | N | 310018467 | LIPOSOMAL DOXORUBICIN |
| 310003695 | 310001548 | 0 | 64 | Palliative (P) | 2016-02-07 | 2016-02-13 | IPILIMUMAB + NIVOLUMAB | N | null | 310018471 | IPILIMUMAB + NIVOLUMAB |
| 310003696 | 310001548 | 1.54 | null | Palliative (P) | 2017-11-07 | 2017-11-09 | Vemurafenib | N | N | 310018471 | CISPLATIN + FLUOROURACIL |
| 310003697 | 310009093 | 1.76 | null | Palliative (P) | 2014-10-18 | 2014-10-18 | Liposomal Doxorubicin (20mg/m2) | N | null | 310018474 | PACLITAXEL |
| 310003698 | 310001549 | null | null | Curative (C) | 2017-11-27 | 2017-12-09 | ECX | N | N | 310018476 | ECX |